14/11/2025
Hemorrhagic Fever outbreaks in Jinka, confirmed the etiological virus
virus disease (MVD) is a rare but severe and often fatal viral hemorrhagic fever in humans, belonging to the same family of viruses (Filoviridae) as Ebola. It was first identified in 1967 during simultaneous outbreaks in Marburg and Frankfurt, Germany, and Belgrade, Serbia, linked to laboratory monkeys imported from Uganda.
Key Characteristics
Egyptian fruit bats (Rousettus aegyptiacus) are thought to be the natural host.
The fatality rate varies, averaging around 50%.
Cases have been reported in several African nations.
Symptoms
Symptoms typically appear within 2 to 21 days and can include high fever, severe headache, and muscle aches. Severe diarrhea, abdominal pain, nausea, and vomiting may follow around the third day. In fatal cases, severe bleeding can occur between days 5 and 7.
Transmission
Human infection often follows exposure to environments where infected bats live. The virus then spreads between people through direct contact with bodily fluids from infected individuals or contaminated surfaces. The virus can remain in semen after recovery. It is not transmitted by air or casual contact. Further details on transmission can be found on the WHO website.
Prevention and Treatment
There are currently no approved vaccines or specific antiviral treatments for MVD.
Supportive medical care can improve survival rates.
Prevention focuses on avoiding contact with potential animal hosts and implementing infection control measures during outbreaks.